EDGAR Filing Documents for 0001193125-14-056904

Form 8-K - Current report:

SEC Accession No. 0001193125-14-056904

Filing Date

2014-02-18

Accepted

2014-02-18 14:55:04

Documents

Period of Report

2014-02-11

Items

Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d679756d8k.htm	8-K	20570
2	EX-3.1	d679756dex31.htm	EX-3.1	46782
3	EX-3.2	d679756dex32.htm	EX-3.2	124421
	Complete submission text file	0001193125-14-056904.txt		192994

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)